The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...

A groundbreaking medication capable of preventing type 2 diabetes by up to 85% is offering new hope to those at risk, a ...

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Commonly used diabetes drugs could lower the risk of cardiometabolic conditions but heighten the risk of gastrointestinal and ...

With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescr ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...